Triamcinolone acetonide 0.00025 MG/MG Topical Ointment — RxCUI 1085633
RxNorm drug concept · Semantic clinical drug
RxCUI 1085633
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1085633
Official nameTriamcinolone acetonide 0.00025 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astriamcinolone acetonide 0.025 % Topical Ointment
FDA products mapped18
Package NDCs mapped38
Reported Medicaid activity (SDUD)1,210,776 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Triamcinolone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Injections treat severe allergic conditions, joint inflammation, certain skin problems and eye inflammation. Creams and ointments calm itchy, inflamed sk...
- Injections are given by a healthcare professional. Ointment is applied as a thin film to the affected area two to three times daily. Nasal spray bottles need priming before first u...
- Possible effects include injection site pain, joint swelling, headache, muscle spasms, cough, sinusitis and bruising. People with diabetes may see higher blood sugar. Tell your doc...
- Call right away for signs of an allergic reaction, fever or infection, a very painful and swollen joint, vision changes, or mood changes. Also report black stools, severe stomach p...
🕸️ Concept Web — How Triamcinolone acetonide 0.00025 MG/MG Topical Oi... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Triamcinolone acetonide 0.00025 MG/MG Topical Ointment
RxCUI 1085633 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Triamcinolone
10759IN -
Triamcinolone acetonide
10761PIN
-
Triamcinolone
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Triamcinolone Topical Ointment
374434SCDF -
Triamcinolone acetonide Topical Ointment
2645397SCDFP -
Triamcinolone Topical Product
1158231SCDG -
Triamcinolone acetonide Topical Product
2661113SCDGP -
Topical Ointment
316985DF -
Topical Product
1151122DFG
-
Triamcinolone Topical Ointment
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Triamcinolone acetonide 0.00025 MG/MG
1085632SCDC
-
Triamcinolone acetonide 0.00025 MG/MG
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Triamcinolone acetonide 0.00025 MG/MG
SCDC · 1085632 -
Triamcinolone Topical Ointment
SCDF · 374434 -
Triamcinolone acetonide Topical Ointment
SCDFP · 2645397 -
Triamcinolone Topical Product
SCDG · 1158231 -
Triamcinolone acetonide Topical Product
SCDGP · 2661113
📦 FDA Products & Package NDCs
18 products · 38 package NDCs
38 package NDCs map to RxCUI 1085633 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00168-0005-80 | 80 g in 1 TUBE (0168-0005-80) | Triamcinolone Acetonide | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1978-02-14 |
| 00168-0006-15 | 15 g in 1 TUBE (0168-0006-15) | Triamcinolone Acetonide | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1978-02-14 |
| 00168-0006-16 | 454 g in 1 JAR (0168-0006-16) | Triamcinolone Acetonide | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1978-02-14 |
| 00168-0006-80 | 80 g in 1 TUBE (0168-0006-80) | Triamcinolone Acetonide | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 1978-02-14 |
| 00713-0228-15 | 1 TUBE in 1 CARTON (0713-0228-15) / 15 g in 1 TUBE | Triamcinolone Acetonide | Cosette Pharmaceuticals, Inc. | 2015-09-10 |
| 00713-0228-31 | 1 TUBE in 1 CARTON (0713-0228-31) / 30 g in 1 TUBE | Triamcinolone Acetonide | Cosette Pharmaceuticals, Inc. | 2024-12-06 |
| 00713-0228-80 | 1 TUBE in 1 CARTON (0713-0228-80) / 80 g in 1 TUBE | Triamcinolone Acetonide | Cosette Pharmaceuticals, Inc. | 2015-09-10 |
| 00713-0229-15 | 1 TUBE in 1 CARTON (0713-0229-15) / 15 g in 1 TUBE | Triamcinolone Acetonide | Cosette Pharmaceuticals, Inc. | 2015-09-10 |
| 00713-0229-80 | 1 TUBE in 1 CARTON (0713-0229-80) / 80 g in 1 TUBE | Triamcinolone Acetonide | Cosette Pharmaceuticals, Inc. | 2015-09-10 |
| 16714-0267-01 | 1 TUBE in 1 CARTON (16714-267-01) / 15 g in 1 TUBE | Triamcinolone acetonide | NorthStar RxLLC | 2022-04-21 |
| 16714-0267-02 | 1 TUBE in 1 CARTON (16714-267-02) / 80 g in 1 TUBE | Triamcinolone acetonide | NorthStar RxLLC | 2022-04-21 |
| 16714-0267-03 | 454 g in 1 JAR (16714-267-03) | Triamcinolone acetonide | NorthStar RxLLC | 2022-04-21 |
| 16714-0268-01 | 1 TUBE in 1 CARTON (16714-268-01) / 15 g in 1 TUBE | Triamcinolone acetonide | NorthStar RxLLC | 2022-04-21 |
| 16714-0276-01 | 1 TUBE in 1 CARTON (16714-276-01) / 15 g in 1 TUBE | Triamcinolone acetonide | NorthStar RxLLC | 2025-04-02 |
| 16714-0276-02 | 1 TUBE in 1 CARTON (16714-276-02) / 80 g in 1 TUBE | Triamcinolone acetonide | NorthStar RxLLC | 2025-04-02 |
| 16714-0276-03 | 454 g in 1 JAR (16714-276-03) | Triamcinolone acetonide | NorthStar RxLLC | 2025-04-02 |
| 33342-0331-15 | 1 TUBE in 1 CARTON (33342-331-15) / 15 g in 1 TUBE | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 33342-0331-54 | 454 g in 1 JAR (33342-331-54) | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 33342-0331-80 | 1 TUBE in 1 CARTON (33342-331-80) / 80 g in 1 TUBE | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 33342-0332-15 | 1 TUBE in 1 CARTON (33342-332-15) / 15 g in 1 TUBE | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 33342-0333-15 | 1 TUBE in 1 CARTON (33342-333-15) / 15 g in 1 TUBE | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 33342-0333-54 | 454 g in 1 JAR (33342-333-54) | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 33342-0333-80 | 1 TUBE in 1 CARTON (33342-333-80) / 80 g in 1 TUBE | Triamcinolone acetonide | Macleods Pharmaceuticals Limited | 2018-11-23 |
| 45802-0049-35 | 1 TUBE in 1 CARTON (45802-049-35) / 15 g in 1 TUBE | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2006-11-10 |
| 45802-0054-05 | 454 g in 1 JAR (45802-054-05) | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2007-07-05 |
| 45802-0054-35 | 1 TUBE in 1 CARTON (45802-054-35) / 15 g in 1 TUBE | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2006-05-12 |
| 45802-0054-36 | 1 TUBE in 1 CARTON (45802-054-36) / 80 g in 1 TUBE | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2007-09-05 |
| 45802-0055-05 | 454 g in 1 JAR (45802-055-05) | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2006-08-04 |
| 45802-0055-35 | 1 TUBE in 1 CARTON (45802-055-35) / 15 g in 1 TUBE | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2007-03-13 |
| 45802-0055-36 | 1 TUBE in 1 CARTON (45802-055-36) / 80 g in 1 TUBE | Triamcinolone Acetonide | Padagis Israel Pharmaceuticals Ltd | 2006-10-02 |
| 50090-3802-00 | 1 TUBE in 1 CARTON (50090-3802-0) / 15 g in 1 TUBE | Triamcinolone Acetonide | A-S Medication Solutions | 2018-11-09 |
| 63629-8841-01 | 80 g in 1 TUBE (63629-8841-1) | Triamcinolone Acetonide | Bryant Ranch Prepack | 2021-09-10 |
| 72162-2335-02 | 1 TUBE in 1 CARTON (72162-2335-2) / 15 g in 1 TUBE | Triamcinolone Acetonide | Bryant Ranch Prepack | 2024-06-18 |
| 72162-2335-04 | 1 TUBE in 1 CARTON (72162-2335-4) / 80 g in 1 TUBE | Triamcinolone Acetonide | Bryant Ranch Prepack | 2024-06-18 |
| 76420-0360-80 | 80 g in 1 TUBE (76420-360-80) | Triamcinolone Acetonide | Asclemed USA, Inc. | 2025-05-23 |
| 76420-0361-00 | 454 g in 1 JAR (76420-361-00) | Triamcinolone Acetonide | Asclemed USA, Inc. | 2025-05-23 |
| 76420-0361-15 | 15 g in 1 TUBE (76420-361-15) | Triamcinolone Acetonide | Asclemed USA, Inc. | 2025-05-23 |
| 76420-0361-80 | 80 g in 1 TUBE (76420-361-80) | Triamcinolone Acetonide | Asclemed USA, Inc. | 2025-05-23 |
Observed labelers:
Macleods Pharmaceuticals Limited (7) ·
NorthStar RxLLC (7) ·
Padagis Israel Pharmaceuticals Ltd (7) ·
Cosette Pharmaceuticals, Inc. (5) ·
Asclemed USA, Inc. (4) ·
E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (4)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.